• WE ARE
    • We Are Early Phase
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • Management
    • Quality Principles
    • How we work
    • Partner
  • EARLY PHASE
    • First-in-Human
    • Interaction
    • Inhalation
    • Infusion & injection
    • Cardiac safety
    • PK/PD
    • Proof of Concept
    • Biosimilars
    • Vaccines
    • Bioequivalence
  • SERVICES
    • Development Consulting
    • Regulatory Consulting
    • Medical Writing
    • Data Management
    • Statistics
    • Multi-Site Service
    • Bioanalytics
  • PATIENT TRIALS
    • Diabetes
    • Obesity and Metabolism
    • Hypertension, Lipids, Inflammation, Endothelial Dysfunction
    • NAFLD/NASH
    • Dermatology
    • Endometriosis
    • Polycystic Ovary Syndrome
    • Medical Device Studies
    • Hemostaseology
    • Hepatology
    • Renal Impairment
    • Your individual request
  • SCIENCE
    • Our approach
    • Publications
  • CAREER
  • NEWS
  • WE ARE
    • We Are Early Phase
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • Management
    • Quality Principles
    • How we work
    • Partner
  • EARLY PHASE
    • First-in-Human
    • Interaction
    • Inhalation
    • Infusion & injection
    • Cardiac safety
    • PK/PD
    • Proof of Concept
    • Biosimilars
    • Vaccines
    • Bioequivalence
  • SERVICES
    • Development Consulting
    • Regulatory Consulting
    • Medical Writing
    • Data Management
    • Statistics
    • Multi-Site Service
    • Bioanalytics
  • PATIENT TRIALS
    • Diabetes
    • Obesity and Metabolism
    • Hypertension, Lipids, Inflammation, Endothelial Dysfunction
    • NAFLD/NASH
    • Dermatology
    • Endometriosis
    • Polycystic Ovary Syndrome
    • Medical Device Studies
    • Hemostaseology
    • Hepatology
    • Renal Impairment
    • Your individual request
  • SCIENCE
    • Our approach
    • Publications
  • CAREER
  • NEWS
All/Company News/

Meet us at EASD 2023 in Hamburg, Germany, from 2 to 6 October 🌟

Anna Vovk . 27. September 2023

✨ We are proud to announce that from October 2 to 6 our CRS Colleagues will attend the 59th annual meeting from European Association for the Study of Diabetes e.V. (EASD) in Hamburg, Germany and are happy to meet you face to face. At the conference you can meet Prof. Dr. Thomas Forst, Dr. med. Edis… read more

Resuscitation Week at CRS Mannheim from 18. to 24. September 2023

Anna Vovk . 25. September 2023

Saving Lives, One Beat at a Time!💢 Life-saving First Aid Skills should not be brought to the attention or discussed only when the emergency situation comes up or has already occurred. At CRS Group, we are proud to support #CPRWeek with our Save a Life initiative! As part of this week, two sessions were organized… read more

From September 26-28, you can find us at BioSpain 2023 in Barcelona, Spain.

Anna Vovk . 22. September 2023

From September 26-28, you can find us at #BIOSPAIN2023 in Barcelona, Spain. The largest biotech event organized by a national bioindustry association in Europe, the event offers 800+ companies and 2000+ attendees the opportunity to collaborate and network. As experts in innovative clinical trial services, we also look forward to the opportunity to meet face-to-face… read more

Opening ceremony new unit Berlin – complete success!

. 2. Mai 2023

The opening of our new location at the @TechnoCampus Berlin in Spandau was a complete success! The weather played along and we were able to celebrate a new chapter in our company history with our customers and befriended companies in a great atmosphere. And of course we would like to thank our colleagues and all… read more

25 Jahre CRS Kiel

. 27. April 2023

Alles begann vor 25 Jahren… Am Freitag, den 28. April 2023, feiert CRS Kiel als ehemaliges „IKP – Institut für Klinische Pharmakologie Prof. Dr. Lücker“ 25-jähriges Firmenjubiläum. Wir freuen uns über diesen Erfolg und auf die nächsten Jahre! read more

Opening ceremony of our new location in Berlin

. 6. April 2023

Dear friends of CRS Clinical Research Services GmbH, You are very welcome to attend the opening ceremony of our new location in Berlin. When? Thursday, April 20, 2023 12 to 20 pm Where? CRS Clinical Research Services Berlin TechnoCampus Berlin Siemensdamm 65 (Eingang Nikolaus-Groß-Weg) 13627 Berlin Please let us know by April 12, 2023 via… read more

Very soon – we are moving to Berlin’s TechnoCampus

. 10. Februar 2023

The keys for our new Berlin facilities at the TechnoCampus will be handed over next week and the excitement couldn’t be greater!   On March 1, the time has finally come and we will be able to welcome our business partners, healthy volunteers and patients at the new location!   The date for our grand… read more

CRS Clinical Research Services Berlin zieht um.

. 3. Februar 2023

CRS Clinical Research Services Berlin wird umziehen: von der Sellerstrasse 31 in Wedding in den modernen TechnoCampus am Berliner Siemensdamm. Wir sind glücklich darüber, unsere klinische Forschung dann in neuen, in jeder Hinsicht auf dem neuesten Stand und ganz nach unserem Bedarf ausgestatteten Räumen fortsetzen und robust für die Zukunft ausbauen zu können. In den… read more

Herzinsuffizienz und Diabetes

Redaktion CRS . 15. August 2022

Um auf die Häufigkeit und das zuweilen tödliche Zusammenspiel dieser Erkrankungen vermehrt aufmerksam zu machen, haben die Deutsche Diabetes Gesellschaft (DDG) und die Deutsche Gesellschaft für Kardiologie (DGK) ein erstes gemeinsames Positionspapier herausgegeben. Unser Geschäftsführer und Chief Medical Officer, Prof. Dr. Thomas Forst, war an dessen Ausarbeitung beteiligt Wir freuen uns, Ihnen den Link zur… read more

100 Jahre Insulin

Redaktion CRS . 21. Juli 2021

2021 jährt sich zum hundertsten Mal ein zentrales Ereignis der Medizingeschichte: Die Isolierung von Insulin. Aus diesem Grund möchten wir Sie recht herzlich zum digitalen Event „100 Jahre Insulin“ einladen. Prof. Dr. Thomas Forst (Geschäftsführer & Chief Medical Officer bei CRS), wird mit seinem Vortrag „Ausblick: Grenzen der subkutanen Insulintherapie – wohin geht der Weg?“ zum… read more

Bayer AG and CRS Management GmbH extend strategic partnership

Redaktion CRS . 5. Mai 2021

We are proud that the strategic partnership between Bayer AG and CRS Clinical Research Services Management GmbH, which has existed since 2013, has now been extended ahead of schedule, and we are pleased that we may continue to support Bayer AG as a reliable partner in its early clinical development. Bayer AG and CRS look… read more

emovis and CRS

Redaktion CRS . 31. März 2021

We are proud to join forces with emovis GmbH in the development of COVID-19 treatments by offering combined clinical trials with healthy volunteers and SARS-CoV-2 patients. For more, see link below. https://www.emovis.de/en/services/covid-trial-unit/ read more

QUICK LINKS
  • WE ARE
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • MANAGEMENT
  • EARLY PHASE
    • First-in-human
    • Cardiac safety
    • Infusion & injection
    • Inhalation
    • Pharmacology
    • Interaction
    • Consultancy
    • Medical Writing
    • Data Management
.
  • PATIENT TRIALS
    • Cardiometabolics
    • Dermatology
    • Women‘s Health
    • Hemostaseology
    • Hepatology
    • Pulmology
    • Renal Impairment
    • Vaccines
    • Your individual request
  • SCIENCE
  • WORK WITH US
EXPERTISE
  • Consultancy
  • Medical Writing
  • Early Phase
FACILITIES
  • Berlin
  • Kiel
  • Mannheim
  • Wuppertal
FÜR PROBANDEN
  • ÜBER STUDIEN
  • AN STUDIEN TEILNEHMEN
  • www.probandeninfo.de
LEGAL
  • PRIVACY
  • IMPRINT
  • DISCLAIMER
  • —
  • Career
    • CURRENT JOB
    • OPPORTUNITIES
Copyright © 2023 CRS. Experts. Early Phase. All rights reserved.